Search

everythinglearnresearchcommunity

for

Search:↓

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Combining stem cell-conditioned media with anti-androgen drugs can improve hair growth in male pattern baldness.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

Alternative treatments show promise for hair growth beyond traditional methods.

Certain hormone treatments can improve acne and related conditions in women.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Early treatment of Female Pattern Hair Loss is important to stop it from getting worse, and various treatments can help, especially in mild to moderate cases.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

New compounds may soon be tested to treat excessive hair growth in women.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Possible link between androgens and COVID-19 severity; more research needed.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.